Studies | Common News Update

Jul152021 by adminNo Comments

NASA studies bigger, better Mars helicopter

Science

ORLANDO, Fla., July 15 (UPI) -- As the Mars helicopter Ingenuity breaks interplanetary records and captures the public's attention, NASA is quietly researching a bigger, better Mars chopper to navigate the Red Planet's rough terrain. The next aircraft sent to Mars has no budget, no confirmed design and no launch date, but researchers at NASA and various universities have studied possible destinations for such a mission. "We're trying to look at building on the success of Ingenuity, and what we could accomplish with a larger, more capable aircraft to Mars in terms of the science we could do and the distances we could go," Teddy Tzanetos, a NASA robotics technologist, said in an interview. The new Mars aircraft either would be a larger version of Ingenuity, with two rotors, or a much bigger...

Dec242020 by adminNo Comments

Studies find having COVID-19 may protect against reinfection

Technology

Two new studies give encouraging evidence that having had COVID-19 may offer some protection against future infectionsBy MARILYNN MARCHIONE AP Chief Medical WriterDecember 24, 2020, 1:30 AM• 3 min readShare to FacebookShare to TwitterEmail this articleTwo new studies give encouraging evidence that having COVID-19 may offer some protection against future infections. Researchers found that people who made antibodies to the coronavirus were much less likely to test positive again for up to six months and maybe longer.The results bode well for vaccines, which provoke the immune system to make antibodies — substances that attach to a virus and help it be eliminated.Researchers found that people with antibodies from natural infections were “at much lower risk ... on the order of the same kind of...

Dec92020 by adminNo Comments

Space Force studies idea of national spaceport authority

Science

ORLANDO, Fla., Dec. 9 (UPI) -- The U.S. Space Force is studying the possibility of merging management of dozens of launch sites in Florida and California under a new operator to keep pace with the growing commercial space industry. "A future spaceport authority would ideally be able to address the needs of all consumers to include national security and civil customers," said Space Force Maj. Nicholas Mercurio, public affairs adviser to chief of space operations Gen. Jay Raymond. Advertisement Reorganizing launch site management would help NASA, the military and private space companies like Elon Musk's SpaceX launch more frequently and with less bureaucratic delay. Creating such a management organization would aid the growth of a space economy, which many banks believe will exceed $ 1 tril...

Aug172020 by adminNo Comments

NSAID painkillers less harmful, just as effective as opioid drugs, studies show

Health

Aug. 17 (UPI) -- Non-steroidal anti-inflammatory drugs, or NSAIDs, are just as effective as opioids at reducing pain from common injuries like strains and sprains, two analyses published Monday by the Annals of Internal Medicine found. People taking NSAIDs also are less likely to experience the potentially harmful risks associated with opioid use, including abuse and addiction, researchers from McMaster University in Canada said. Advertisement The findings come as the United States is still dealing with an "opioid epidemic" fueled by misuse and abuse of used prescribed pain medications, according to the researchers. "Although there are many treatment options available for addressing acute pain from musculoskeletal injuries, only a limited number of pharmacologic options are currently sup...

Jun42020 by adminNo Comments

Authors retract journal studies on hydroxychloroquine use for COVID-19

Health

June 4 (UPI) -- The Lancet and New England Journal of Medicine announced Thursday that the authors of published studies on use of the anti-malaria drug hydroxychloroquine to treat COVID-19 have retracted their findings. The retractions come after reports questioned the validity of data used in the studies, and researchers and third-party reviewers could not verify data supplied to them for the study. Advertisement Published May 1, the New England study found COVID-19 patients with cardiovascular disease were at greater risk of death if treated with the drug. On May 22, the Lancet study found the drug offered no clinical benefit in treating patients infected with the new coronavirus, SARS-CoV-2, and may also cause significant heart-related side effects. "We always aspire to perform our re...